China · Delayed Price · Currency is CNY Nanjing Hicin Pharmaceutical Company Description
Nanjing Hicin Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of chemical preparations, APIs, and intermediates.
The company’s products include landiolol hydrochloride, rivaroxaban, tigecycline, torasemide, cefuroxime sodium, ceftriaxone hydrochloride, ganciclovir sodium, adenosine monophosphate, and adenosine monophosphate for injection; voglibose tablets, lansoprazole enteric-coated tablets, amlodipine besylate tablets, and glucosamine sulfate effervescent tablets/granules; and raw materials, intermediates, and other products.
Its products are used in cardiovascular and cerebrovascular, diuretic, anti-infection, digestive system, immune regulation, hypoglycemic, orthopedics, and other treatment areas.
Nanjing Hicin Pharmaceutical Co., Ltd. was founded in 2003 and is headquartered in Nanjing, China.
| Country | China |
| Founded | 2003 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 548 |
| CEO | Yuping Cao |
Contact Details
Address: No.1 Hengfa Road Nanjing, 210046 China | |
| Phone | 86 25 8324 1873 |
| Website | hicin.cn |
Stock Details
| Ticker Symbol | 300584 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100002F44 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Yuping Cao | GM and Chairman of the Board |
| Mingsheng Feng | Deputy GM and Director |
| Li Qun Wang | Secretary and Deputy GM |
| Jian Ren Chen | Financial Director |
| Xiaowei Li | Accounting Supervisor |
| Guangyao Liu | Deputy General Manager |
| Wei Biao Yue | Deputy General Manager |